Maria Fazia

University of Messina — Italy

Medicine · Health Sciences

17h-index2.7kcitations29works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory mediators and NSAID effects(12), Protease and Inhibitor Mechanisms(7), Antiplatelet Therapy and Cardiovascular Diseases(6), Atherosclerosis and Cardiovascular Diseases(5), Lipoproteins and Cardiovascular Health(4)

Publications29 total

Internet of Things and Edge Cloud Computing Roadmap for Manufacturing
IEEE Cloud Computing·2016· 253 cited
EXPRESSION OF CB1 AND CB2 IN HUMAN ATHEROSCLEROTIC PLAQUES
Atherosclerosis Supplements·2008
Oxidative stress, inflammation and atherosclerotic plaque development
International Congress Series·2007· 21 cited
PO11-313 SUPPRESSION OF 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE AS A BASIS OF ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS
Atherosclerosis Supplements·2007
PO11-310 COMPARABLE, DIFFUSE INFLAMMATORY BURDEN IN CORONARY, CAROTID AND ILIAC PLAQUES FROM PATIENTS WHO DIED FROM MYOCARDIAL INFARCTION
Atherosclerosis Supplements·2007
WITHDRAWN: Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives
Pharmacology & Therapeutics·2007· 1 cited
Suppression of Rage as a Basis of Simvastatin-Dependent Plaque Stabilization in Type 2 Diabetes
Arteriosclerosis Thrombosis and Vascular Biology·2006· 156 citedOpen Access
COX-2 and Atherosclerosis
Journal of Cardiovascular Pharmacology·2006· 81 cited
Cyclooxygenase-2 inhibition: Vascular inflammation and cardiovascular risk
Current Atherosclerosis Reports·2006· 17 cited
Role of angiotensin II receptor blockers in atherosclerotic plaque stability
Expert Opinion on Pharmacotherapy·2006· 14 cited
Tu-P7:280 Hur protein as potential modulator of angiotensin II type 1 receptor expression in human atherosclerotic plaque
Atherosclerosis Supplements·2006
Tu-P7:287 Overexpression of toll like receptor 4 as a basis of cyclooxygenase 2-dependent atherosclerotic plaque instability in humans
Atherosclerosis Supplements·2006
Mo-PL1:4 The interplay of dyslipidemia and inflammation in the evolution of atherosclerotic plaque
Atherosclerosis Supplements·2006
Tu-P7:282 Overexpression of protein AUF1 as a protective mechanism against PGE2-dependent atherosclerotic plaque instability in humans
Atherosclerosis Supplements·2006
Relationship between Reduced BCL-2 Expression in Circulating Mononuclear Cells and Early Nephropathy in Type 1 Diabetes
International Journal of Immunopathology and Pharmacology·2005· 22 cited
Association Between Prostaglandin E Receptor Subtype EP4 Overexpression and Unstable Phenotype in Atherosclerotic Plaques in Human
Arteriosclerosis Thrombosis and Vascular Biology·2005· 98 cited
Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans
Arteriosclerosis Thrombosis and Vascular Biology·2005· 171 cited
Recenti vedute sul meccanismo molecolare d’azione dei bloccanti recettoriali dell’angiotensina II di tipo 1 e sul loro contributo alla stabilizzazione della placca aterosclerotica
Recenti Progressi in Medicina·2004
[New insights on the molecular mechanisms of type-1 angiotensin II receptor blockers and their contribution to atherosclerotic plaque stabilization].
PubMed·2004
Increased Expression of Transforming Growth Factor-β1 as a Stabilizing Factor in Human Atherosclerotic Plaques
Stroke·2004· 100 cited
page 1 of 2Next →

Frequent Co-authors

Francesco Cipollone(27), Andrea Mezzetti(26), Annalisa Iezzi(19), Franco Cuccurullo(17), Domenico De Cesare(13), S Ucchino(11), Barbara Pini(9), Chiara Cuccurullo(8), Francesco Chiarelli(8), Francesco Spigonardo(8), C. Cuccurullo(6), Raffaella Muraro(4), Roberto Bei(4), Marco Bucci(4), Matteo Marini(3), Leonardo Paloscia(3), F Spigonardo(3), Mirco Zucchelli(2), Ann Marie Schmidt(2), Cesaria Prontera(2)